Page last updated: 2024-10-21

3,4-dichloroisocoumarin and Heart Failure

3,4-dichloroisocoumarin has been researched along with Heart Failure in 1 studies

3,4-dichloroisocoumarin : A member of the class of isocoumarins that is isocoumarin substituted by chloro groups at positions 3 and 4. It is a serine protease inhibitor.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mital, S1
Loke, KE1
Slater, JP1
Addonizio, L1
Gersony, WM1
Hintze, TH1

Other Studies

1 other study available for 3,4-dichloroisocoumarin and Heart Failure

ArticleYear
Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts.
    The American journal of cardiology, 1999, Jun-17, Volume: 83, Issue:12A

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors

1999